MedTrace Logo

Galvus on Met Phase 4 Study : Study to Evaluate the Efficacy and Safety of Early Combination of Vildagliptin and Metformin in Patients With Type 2 Diabetes Mellitus

NCT00975065 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 266

Last updated 2012-08-23

No results posted yet for this study

Summary

The study design of this trial is open-label, randomized, multi-center, parallel-group study.

Conditions

Interventions

DRUG

vildagliptin 50 mg bid plus metformin 1500mg (Galvus+Diabex)

vildagliptin 50 mg bid plus metformin 1500mg

DRUG

metformin 1500mg plus metformin 500mg or 1000mg (Diabex)

metformin 1500mg plus metformin 500mg or 1000mg

Sponsors & Collaborators

  • Handok Inc.

    lead INDUSTRY

Principal Investigators

  • Sei Hyun Baik, professor · Korea University Guro Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2011-12-31
Completion
2012-04-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00975065 on ClinicalTrials.gov